Consultant Profile

Prof Gordon Wishart

Name:
Prof Gordon Wishart MB ChB MA (Cantab.) MD FRCS (Gen.)
Practicing at:
Spire Cambridge Lea Hospital
Specialties:
  • Breast care
    • Benign breast problems
    • Breast cancer
  • General surgery
    • Breast surgery
    • Endocrine surgery
    • Parathyroid disease
    • Thyroid disease
  • Oncology
    • Breast cancer
    • Breast disease
Special clinical interests:

Breast cancer surgery
Sentinel node biopsy
Immediate breast reconstruction (joint procedure with plastic surgeon)
Focused parathyroidectomy
Medico-legal work in breast cancer field (clinical negligence, delay in breast cancer diagnosis)

Research interests:

Variation in breast cancer survival, sentinel node biopsy, new breast cancer technology. I recently put together and lead the team that built a new breast cancer survival and treatment benefit model called PREDICT (www.predict.nhs.uk)

Current NHS and /or university posts:

Professor of Cancer Surgery, Anglia Ruskin University, Cambridge, UK
Former Director Cambridge Breast Unit 2005-2010

Year of first medical qualification:
1983
Current membership(s) of professional, national and regional bodies:

Association of Breast Surgeons
British Breast Group

 
Contact Details 
Telephone number to make a private appointment:
01223 266990
Personal email address:
Availability:
Twice weekly one-stop breast clinics with access to all breast imaging and biopsy if required
 
Background Information 
Professional profile:

Professor Wishart is a consultant breast & endocrine surgeon covering all aspects of breast, thyroid and parathyroid surgery. Twice weekly clinics allow access to triple assessment (breast examination, breast imaging and biopsy) for patients with breast disease with access to all breast cancer surgery including immediate breast reconstruction with colleague plastic surgeons. As the former Director of the Cambridge Breast Unit (2005-2010), Professor Wishart now has a national and international reputation for providing the highest quality of multidisciplinary and evidence-based care for patients with breast cancer. Much of the research evidence has been based on Cambridge-based clinical research studies that he has personally lead. He now has a growing medico-legal workload, providing exert medical reports in cases of clinical negligence in breast cancer, especially delay in diagnosis following his development of a new breast cancer survival model that was launched in 2010 called PREDICT (www.predict.nhs.uk).

Personal profile:

As well as his busy clinical and research workload, Professor Wishart is co-founder and Medical Director of International Health Technology, a Cambridge-based company developing cutting edge cancer screening services and a route to market for new technology. He was appointed as Professor of Cancer Surgery at Anglia Ruskin University in December 2008 and recently established a state of the art diagnostic and treatment centre for breast cancer in Athens (www.cambridgebreastclinic.com).

Recommended links:


These links are outside Spire Healthcare's control and we take no responsibility for the information they contain.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Prof Gordon Wishart

Professor Gordon Wishart Breast care, General surgery & Oncology Consultant, Cambridge, private hospital specialist.

Womens Health at Spire Cambridge Lea Hospital


Click here to read more

Embarrassing Bodies at Spire Cambridge Lea Hospital


Channel 4's Embarassing Bodies will soon feature episodes at Spire Cambridge Lea Hospital including Professor Gordon Wishart

© Spire Healthcare Group plc (2016)